A detailed history of Great West Life Assurance CO transactions in Bio Techne Corp stock. As of the latest transaction made, Great West Life Assurance CO holds 71,262 shares of TECH stock, worth $5.41 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
71,262
Previous 66,696 6.85%
Holding current value
$5.41 Million
Previous $4.78 Million 19.21%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$70.96 - $82.35 $324,003 - $376,010
4,566 Added 6.85%
71,262 $5.7 Million
Q2 2024

Aug 12, 2024

BUY
$62.12 - $84.15 $490,623 - $664,616
7,898 Added 13.43%
66,696 $4.78 Million
Q1 2024

May 13, 2024

BUY
$65.98 - $77.09 $294,072 - $343,590
4,457 Added 8.2%
58,798 $4.14 Million
Q4 2023

Feb 13, 2024

BUY
$52.83 - $78.22 $205,667 - $304,510
3,893 Added 7.72%
54,341 $4.18 Million
Q3 2023

Nov 14, 2023

SELL
$67.52 - $89.42 $46,926 - $62,146
-695 Reduced 1.36%
50,448 $3.43 Million
Q2 2023

Aug 10, 2023

SELL
$73.76 - $85.98 $209,920 - $244,699
-2,846 Reduced 5.27%
51,143 $4.19 Million
Q1 2023

May 12, 2023

SELL
$71.62 - $86.62 $5,156 - $6,236
-72 Reduced 0.13%
53,989 $4.01 Million
Q4 2022

Feb 10, 2023

BUY
$80.67 - $352.29 $2.84 Million - $12.4 Million
35,229 Added 187.07%
54,061 $4.5 Million
Q3 2022

Nov 01, 2022

BUY
$282.54 - $391.85 $5.32 Million - $7.38 Million
18,832 New
18,832 $5.34 Million
Q2 2022

Aug 09, 2022

SELL
$322.67 - $449.65 $699,548 - $974,841
-2,168 Reduced 10.28%
18,918 $6.56 Million
Q1 2022

May 12, 2022

SELL
$353.85 - $487.79 $256,541 - $353,647
-725 Reduced 3.32%
21,086 $9.58 Million
Q4 2021

Feb 14, 2022

BUY
$456.15 - $525.06 $138,669 - $159,618
304 Added 1.41%
21,811 $11.3 Million
Q3 2021

Nov 15, 2021

SELL
$444.87 - $538.88 $1.64 Million - $1.98 Million
-3,681 Reduced 14.61%
21,507 $10.5 Million
Q2 2021

Aug 11, 2021

BUY
$387.35 - $450.26 $3.84 Million - $4.46 Million
9,909 Added 64.85%
25,188 $11.3 Million
Q1 2021

May 17, 2021

SELL
$314.62 - $411.0 $329,407 - $430,317
-1,047 Reduced 6.41%
15,279 $5.82 Million
Q4 2020

Feb 16, 2021

SELL
$246.9 - $321.87 $486,393 - $634,083
-1,970 Reduced 10.77%
16,326 $5.18 Million
Q3 2020

Nov 17, 2020

SELL
$232.22 - $282.96 $18.5 Million - $22.6 Million
-79,839 Reduced 81.36%
18,296 $4.53 Million
Q3 2020

Nov 13, 2020

BUY
$232.22 - $282.96 $18.3 Million - $22.3 Million
78,903 Added 410.27%
98,135 $24.3 Million
Q2 2020

Aug 17, 2020

SELL
$185.43 - $279.56 $114,224 - $172,208
-616 Reduced 3.1%
19,232 $5.07 Million
Q1 2020

May 14, 2020

BUY
$161.17 - $221.51 $239,982 - $329,828
1,489 Added 8.11%
19,848 $3.76 Million
Q4 2019

Feb 11, 2020

BUY
$189.68 - $222.09 $3.48 Million - $4.08 Million
18,359 New
18,359 $4.03 Million
Q3 2019

Oct 25, 2019

SELL
$183.56 - $216.72 $4.1 Million - $4.84 Million
-22,341 Closed
0 $0
Q2 2019

Jul 31, 2019

SELL
$188.72 - $215.43 $116,440 - $132,920
-617 Reduced 2.69%
22,341 $0
Q1 2019

May 08, 2019

SELL
$136.09 - $200.44 $29,259 - $43,094
-215 Reduced 0.93%
22,958 $4.56 Million
Q4 2018

Feb 12, 2019

BUY
$132.75 - $203.8 $197,001 - $302,439
1,484 Added 6.84%
23,173 $3.11 Million
Q3 2018

Nov 13, 2018

BUY
$147.44 - $204.11 $442 - $612
3 Added 0.01%
21,689 $4.43 Million
Q2 2018

Aug 10, 2018

SELL
$144.9 - $165.58 $132,293 - $151,174
-913 Reduced 4.04%
21,686 $3.21 Million
Q1 2018

May 10, 2018

BUY
$131.46 - $151.04 $98,200 - $112,826
747 Added 3.42%
22,599 $3.41 Million
Q4 2017

Feb 09, 2018

SELL
$121.17 - $134.75 $84,819 - $94,325
-700 Reduced 3.1%
21,852 $2.83 Million
Q3 2017

Nov 09, 2017

BUY
$113.59 - $123.78 $2.56 Million - $2.79 Million
22,552
22,552 $2.72 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.98B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.